Lower copay and oral administration: Predictors of first-fill adherence to new asthma prescriptions

Zackary Berger, William Kimbrough, Colleen Gillespie, Joseph A. Boscarino, G. Craig Wood, Zhengmin Qian, J. B. Jones, Nirav R. Shah

Research output: Contribution to journalArticle

Abstract

Background: Nonadherence to asthma medications is associated with increased emergency department visits and hospitalizations. If adherence is to be improved, first-fill adherence is the first goal to meet after the physician and patient have decided to begin treatment. Little is known about first-fill adherence with asthma medications and the factors for no-fill. Objective: The goal of the study was to examine the proportion of patients who fill a new prescription for an asthma medication and analyze characteristics associated with this first-fill. Methods: This retrospective cohort study linked electronic health records with pharmacy claims. The cohort was comprised of 2023 patients aged 18 years or older who sought care from the Geisinger Clinic, had Geisinger Health Planpharmacy benefits, and were prescribed an asthma medication for the first time between 2002 and 2006. The primary outcome of interest was first-time prescription filled by the patient within 30 days of the prescription order date. Covariates examined included factors related to the patient (ie, age, sex, and ethnicity), comorbidities and utilization (ie, Charlson comorbidity index, number of office visits, number of additional medications), asthma treatment(ie, deliveryroute, pharmacologic class), and pharmacy copayamount. Alogistic-regression model was used to determine covariates associated with first-fill. Results: The overall first-fill rate for new asthma medications was 78%. First-fill rate was lower for patients with a copay above the mean of $12 (odds ratio = 0.76; 95% confidence interval, 0.58-0.99) and higher for patient sprescribed oral plus inhaled medications (versus inhaled only, odds ratio = 3.91; 95% confidence interval, 2. 15-7. 11). Conclusions: Several factors associated with failing to fill an initial prescription for asthma can be addressed through simple interventions: screening for difficulties a patient may have in filling prescriptions, avoiding non formulary medications, and recognizing the barrier that high copays present. In addition, for employers and policy makers, decreasing copay may improve adherence and, therefore, asthma control.

Original languageEnglish (US)
Pages (from-to)174-179
Number of pages6
JournalAmerican Health and Drug Benefits
Volume2
Issue number4
StatePublished - 2009
Externally publishedYes

Fingerprint

Prescriptions
Oral Administration
Asthma
Comorbidity
Odds Ratio
Confidence Intervals
Formularies
Office Visits
First Fill
Adherence
Predictors
Prescription
Medication
Electronic Health Records
Insurance Benefits
Administrative Personnel
Hospital Emergency Service
Hospitalization
Cohort Studies
Retrospective Studies

ASJC Scopus subject areas

  • Health Policy
  • Strategy and Management

Cite this

Berger, Z., Kimbrough, W., Gillespie, C., Boscarino, J. A., Wood, G. C., Qian, Z., ... Shah, N. R. (2009). Lower copay and oral administration: Predictors of first-fill adherence to new asthma prescriptions. American Health and Drug Benefits, 2(4), 174-179.

Lower copay and oral administration : Predictors of first-fill adherence to new asthma prescriptions. / Berger, Zackary; Kimbrough, William; Gillespie, Colleen; Boscarino, Joseph A.; Wood, G. Craig; Qian, Zhengmin; Jones, J. B.; Shah, Nirav R.

In: American Health and Drug Benefits, Vol. 2, No. 4, 2009, p. 174-179.

Research output: Contribution to journalArticle

Berger, Z, Kimbrough, W, Gillespie, C, Boscarino, JA, Wood, GC, Qian, Z, Jones, JB & Shah, NR 2009, 'Lower copay and oral administration: Predictors of first-fill adherence to new asthma prescriptions', American Health and Drug Benefits, vol. 2, no. 4, pp. 174-179.
Berger, Zackary ; Kimbrough, William ; Gillespie, Colleen ; Boscarino, Joseph A. ; Wood, G. Craig ; Qian, Zhengmin ; Jones, J. B. ; Shah, Nirav R. / Lower copay and oral administration : Predictors of first-fill adherence to new asthma prescriptions. In: American Health and Drug Benefits. 2009 ; Vol. 2, No. 4. pp. 174-179.
@article{9f05a597648d4c779a0b650be98a32ca,
title = "Lower copay and oral administration: Predictors of first-fill adherence to new asthma prescriptions",
abstract = "Background: Nonadherence to asthma medications is associated with increased emergency department visits and hospitalizations. If adherence is to be improved, first-fill adherence is the first goal to meet after the physician and patient have decided to begin treatment. Little is known about first-fill adherence with asthma medications and the factors for no-fill. Objective: The goal of the study was to examine the proportion of patients who fill a new prescription for an asthma medication and analyze characteristics associated with this first-fill. Methods: This retrospective cohort study linked electronic health records with pharmacy claims. The cohort was comprised of 2023 patients aged 18 years or older who sought care from the Geisinger Clinic, had Geisinger Health Planpharmacy benefits, and were prescribed an asthma medication for the first time between 2002 and 2006. The primary outcome of interest was first-time prescription filled by the patient within 30 days of the prescription order date. Covariates examined included factors related to the patient (ie, age, sex, and ethnicity), comorbidities and utilization (ie, Charlson comorbidity index, number of office visits, number of additional medications), asthma treatment(ie, deliveryroute, pharmacologic class), and pharmacy copayamount. Alogistic-regression model was used to determine covariates associated with first-fill. Results: The overall first-fill rate for new asthma medications was 78{\%}. First-fill rate was lower for patients with a copay above the mean of $12 (odds ratio = 0.76; 95{\%} confidence interval, 0.58-0.99) and higher for patient sprescribed oral plus inhaled medications (versus inhaled only, odds ratio = 3.91; 95{\%} confidence interval, 2. 15-7. 11). Conclusions: Several factors associated with failing to fill an initial prescription for asthma can be addressed through simple interventions: screening for difficulties a patient may have in filling prescriptions, avoiding non formulary medications, and recognizing the barrier that high copays present. In addition, for employers and policy makers, decreasing copay may improve adherence and, therefore, asthma control.",
author = "Zackary Berger and William Kimbrough and Colleen Gillespie and Boscarino, {Joseph A.} and Wood, {G. Craig} and Zhengmin Qian and Jones, {J. B.} and Shah, {Nirav R.}",
year = "2009",
language = "English (US)",
volume = "2",
pages = "174--179",
journal = "American Health and Drug Benefits",
issn = "1942-2962",
publisher = "Engage Healthcare Communications, Inc.",
number = "4",

}

TY - JOUR

T1 - Lower copay and oral administration

T2 - Predictors of first-fill adherence to new asthma prescriptions

AU - Berger, Zackary

AU - Kimbrough, William

AU - Gillespie, Colleen

AU - Boscarino, Joseph A.

AU - Wood, G. Craig

AU - Qian, Zhengmin

AU - Jones, J. B.

AU - Shah, Nirav R.

PY - 2009

Y1 - 2009

N2 - Background: Nonadherence to asthma medications is associated with increased emergency department visits and hospitalizations. If adherence is to be improved, first-fill adherence is the first goal to meet after the physician and patient have decided to begin treatment. Little is known about first-fill adherence with asthma medications and the factors for no-fill. Objective: The goal of the study was to examine the proportion of patients who fill a new prescription for an asthma medication and analyze characteristics associated with this first-fill. Methods: This retrospective cohort study linked electronic health records with pharmacy claims. The cohort was comprised of 2023 patients aged 18 years or older who sought care from the Geisinger Clinic, had Geisinger Health Planpharmacy benefits, and were prescribed an asthma medication for the first time between 2002 and 2006. The primary outcome of interest was first-time prescription filled by the patient within 30 days of the prescription order date. Covariates examined included factors related to the patient (ie, age, sex, and ethnicity), comorbidities and utilization (ie, Charlson comorbidity index, number of office visits, number of additional medications), asthma treatment(ie, deliveryroute, pharmacologic class), and pharmacy copayamount. Alogistic-regression model was used to determine covariates associated with first-fill. Results: The overall first-fill rate for new asthma medications was 78%. First-fill rate was lower for patients with a copay above the mean of $12 (odds ratio = 0.76; 95% confidence interval, 0.58-0.99) and higher for patient sprescribed oral plus inhaled medications (versus inhaled only, odds ratio = 3.91; 95% confidence interval, 2. 15-7. 11). Conclusions: Several factors associated with failing to fill an initial prescription for asthma can be addressed through simple interventions: screening for difficulties a patient may have in filling prescriptions, avoiding non formulary medications, and recognizing the barrier that high copays present. In addition, for employers and policy makers, decreasing copay may improve adherence and, therefore, asthma control.

AB - Background: Nonadherence to asthma medications is associated with increased emergency department visits and hospitalizations. If adherence is to be improved, first-fill adherence is the first goal to meet after the physician and patient have decided to begin treatment. Little is known about first-fill adherence with asthma medications and the factors for no-fill. Objective: The goal of the study was to examine the proportion of patients who fill a new prescription for an asthma medication and analyze characteristics associated with this first-fill. Methods: This retrospective cohort study linked electronic health records with pharmacy claims. The cohort was comprised of 2023 patients aged 18 years or older who sought care from the Geisinger Clinic, had Geisinger Health Planpharmacy benefits, and were prescribed an asthma medication for the first time between 2002 and 2006. The primary outcome of interest was first-time prescription filled by the patient within 30 days of the prescription order date. Covariates examined included factors related to the patient (ie, age, sex, and ethnicity), comorbidities and utilization (ie, Charlson comorbidity index, number of office visits, number of additional medications), asthma treatment(ie, deliveryroute, pharmacologic class), and pharmacy copayamount. Alogistic-regression model was used to determine covariates associated with first-fill. Results: The overall first-fill rate for new asthma medications was 78%. First-fill rate was lower for patients with a copay above the mean of $12 (odds ratio = 0.76; 95% confidence interval, 0.58-0.99) and higher for patient sprescribed oral plus inhaled medications (versus inhaled only, odds ratio = 3.91; 95% confidence interval, 2. 15-7. 11). Conclusions: Several factors associated with failing to fill an initial prescription for asthma can be addressed through simple interventions: screening for difficulties a patient may have in filling prescriptions, avoiding non formulary medications, and recognizing the barrier that high copays present. In addition, for employers and policy makers, decreasing copay may improve adherence and, therefore, asthma control.

UR - http://www.scopus.com/inward/record.url?scp=77953407429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953407429&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77953407429

VL - 2

SP - 174

EP - 179

JO - American Health and Drug Benefits

JF - American Health and Drug Benefits

SN - 1942-2962

IS - 4

ER -